Early detection remains one of the most powerful tools in the fight against breast cancer. Yet traditional paper-based screening methods have limited the ability to consistently identify high-risk patients. That’s why Midstate Radiology Associates adopted the Ambry CARE Program® (CARE) to improve universal cancer risk stratification.
Jenna Cooke, DNP, APRN, FNP-C, CGRA provides an overview of this advanced digital screening tool, designed to improve access, accuracy and patient outcomes.
The Transition to Digital Risk Screening
From 2018 to 2021, Midstate Radiology Associates relied on paper family history forms for cancer risk assessments. Since transitioning to the digital CARE platform, we have seen:
- A 400% increase in identifying patients eligible for breast MRI
- A 60% boost in patients pursuing genetic testing
- Over 6,000 lives impacted through proactive care
Looking Ahead: The Future of Risk Screening
The success of our transition to digital risk assessment highlights the potential for healthcare providers everywhere to improve outcomes through innovation. By embracing tools like CARE, imaging centers can identify more high-risk patients, support informed decision-making, and ultimately save lives.
For an in-depth look at the study results and outcomes, read the full article here.
